Liberate Bio

Liberate Bio is a biotechnology company headquartered in Boston, Massachusetts. The company leverages machine learning, advanced chemistry, and molecular biology techniques to identify novel delivery vehicles for oligonucleotides. Liberate Bio is utilizing automation, in vivo high-throughput screening, and machine learning to accelerate the discovery of novel extrahepatic delivery vehicles. Our mission is to liberate patients from genetic diseases by advancing non-viral delivery technologies for nucleic acid cargoes such as ASOs, siRNA, mRNA, and coding gene editors.